NSD3 and cancer: Likewise, nonsense mutations in NSD3, such as, E1181K and T2342A, enhance the growth of cancer cells and xenograft tumors by disrupting an autoinhibitory loop in the NSD3 protein, thereby increasing enzymatic activity [47,48].